S 2665
Drug Shortage Prevention Act of 2025
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
The Drug Shortage Prevention Act of 2025 aims to improve the nation’s ability to respond to drug shortages. It requires manufacturers of critical drugs to notify the government of potential disruptions to the supply chain, such as discontinuances or issues with active pharmaceutical ingredients, at least six months in advance or as soon as possible. The notification must include details about the cause of the disruption, alternative sources, and expected duration. The law also mandates regular reporting on supply chains to help identify and address potential vulnerabilities.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.